StockLens

AUROPHARMA vs MAXHEALTH vs CIPLA vs DRREDDY: which stock is better?

Aurobindo Pharma Limited (AUROPHARMA) has the highest StockLens rating in this group at 8.1/10 (Excellent).

MetricAUROPHARMAMAXHEALTHCIPLADRREDDY
Overall rating8.1/10 (Excellent)5.0/10 (Average)5.0/10 (Average)4.5/10 (Average)
Long-term viewStrong long-term candidateNeutral (watchlist)Neutral (watchlist)Neutral (watchlist)
Trade biasStrong longNo clear edgeLong biasLong bias
Share price₹1,796.30₹1,022.85₹1,417.00₹1,398.20
Market cap₹1,03,355 Cr₹99,557 Cr₹1,14,478 Cr₹1,16,563 Cr
P/E26.072.439.541.6
Return on equity10.7%12.8%8.3%7.3%
Debt / equity0.220.330.020.19
Revenue growth (YoY)+23.9%+20.3%-1.1%-1.5%
1-year return+55.6%-6.6%-6.5%+15.4%

Educational information, not investment advice. Data from Yahoo Finance and NSE Indices; prices may be delayed.